Outcomes of persons with coronavirus disease 2019 in hospitals with and without standard treatment with (hydroxy)chloroquine

OBJECTIVE: To compare survival of individuals with coronavirus disease 2019 (COVID-19) treated in hospitals that either did or did not routinely treat patients with hydroxychloroquine or chloroquine. METHODS: We analysed data of COVID-19 patients treated in nine hospitals in the Netherlands. Inclusi...

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, Edgar JG., Collard, Didier, Van Assen, Sander, Beudel, Martijn, Bomers, Marije K., Buijs, Jacqueline, De Haan, Lianne R., De Ruijter, Wouter, Douma, Renée A., Elbers, Paul WG., Goorhuis, Abraham, Gritters van den Oever, Niels C., Knarren, Lieve GHH., Moeniralam, Hazra S., Mostard, Remy LM., Quanjel, Marian JR., Reidinga, Auke C., Renckens, Roos, Van Den Bergh, Joop PW., Vlasveld, Imro N., Sikkens, Jonne J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554450/
https://www.ncbi.nlm.nih.gov/pubmed/33068758
http://dx.doi.org/10.1016/j.cmi.2020.10.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554450/
https://www.ncbi.nlm.nih.gov/pubmed/33068758
http://dx.doi.org/10.1016/j.cmi.2020.10.004

Ejemplares similares